Stay updated on Pembrolizumab vs Ipilimumab in Melanoma Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab vs Ipilimumab in Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab vs Ipilimumab in Melanoma Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2 on the page.
    Difference
    0.1%
    Check dated 2026-04-16T10:55:44.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    No Change Detected
  4. Check
    25 days ago
    Change Detected
    Summary
    Added related topic links for Melanoma and MedlinePlus Genetics.
    Difference
    0.2%
    Check dated 2026-03-25T21:14:41.000Z thumbnail image
  5. Check
    32 days ago
    Change Detected
    Summary
    Revision: v3.5.0 added; Melanoma-related topics (MedlinePlus Genetics) and the older Revision: v3.4.3 removed.
    Difference
    0.2%
    Check dated 2026-03-18T18:10:26.000Z thumbnail image
  6. Check
    39 days ago
    Change Detected
    Summary
    Page revision updated from v3.4.2 to v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-11T17:14:11.000Z thumbnail image
  7. Check
    46 days ago
    Change Detected
    Summary
    Added Melanoma as a topic and linked related topics, including MedlinePlus Genetics.
    Difference
    0.2%
    Check dated 2026-03-04T13:46:22.000Z thumbnail image
  8. Check
    68 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2; removed the lapse-in-funding notice and the government operating status update, and removed Revision: v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-11T04:41:03.000Z thumbnail image

Stay in the know with updates to Pembrolizumab vs Ipilimumab in Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab vs Ipilimumab in Melanoma Clinical Trial page.